Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

InnovAge Holding Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

InnovAge Holding hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag	1.7%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	-US$0.23
Erwartete Dividendenrendite in 3 Jahren	0%

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 10

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Jun 08

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

Sep 13

InnovAge names Richard Feifer as chief medical officer

Aug 17

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

Jul 27

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

May 12

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Apr 14

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Mar 24

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Mar 19

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

Nov 16

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Jul 28

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von INNV in der Vergangenheit stabil geblieben ist.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von INNV gestiegen sind.

Dividendenrendite im Vergleich zum Markt

InnovAge Holding Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von INNV im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (INNV)	n/a
Untere 25 % des Marktes (US)	1.5%
Markt Top 25 % (US)	4.7%
Branchendurchschnitt (Healthcare)	1.7%
Analystenprognose in 3 Jahren (INNV)	0%

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von INNV im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von INNV im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von INNV, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da INNV keine Ausschüttungen gemeldet hat.

InnovAge Holding Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Recent updates

New minor risk - Share price stability

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

Price target decreased by 12% to US$6.00

InnovAge Holding Corp. Reiterates Financial Guidance for the Full Fiscal Year 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)

InnovAge Holding Corp. to Report Q3, 2024 Results on May 07, 2024

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Price target decreased by 9.3% to US$6.50

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

InnovAge Holding Corp. to Report Q2, 2024 Results on Feb 06, 2024

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Consensus EPS estimates fall by 113%

Consensus EPS estimates fall by 127%, revenue upgraded

First quarter 2024 earnings: EPS misses analyst expectations

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

InnovAge Holding Corp. to Report Q1, 2024 Results on Nov 07, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

Consensus EPS estimates fall by 60%

Price target decreased by 8.3% to US$7.33

InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance

Full year 2023 earnings: EPS misses analyst expectations

InnovAge Holding Corp. to Report Q4, 2023 Results on Sep 12, 2023

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Now 21% undervalued

InnovAge Holding Corp. Announces CFO Changes

Now 20% undervalued after recent price drop

InnovAge Holding Corp.(NasdaqGS:INNV) dropped from Russell Small Cap Comp Value Index

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Now 24% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.24 loss

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

InnovAge Holding Corp. to Report Q2, 2023 Results on Feb 07, 2023

Price target increased to US$7.00

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

InnovAge Holding Corp. to Report Q1, 2023 Results on Nov 08, 2022

InnovAge Holding Corp. Not Provides Earnings Guidance for the Fiscal Year 2023

Investor sentiment improved over the past week

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

InnovAge Holding Corp. to Report Q4, 2022 Results on Sep 13, 2022

InnovAge Holding Corp. Appoints Kathy Andreasen as Chief People Officer

InnovAge Holding Corp. Names Richard Feifer as Chief Medical Officer

InnovAge names Richard Feifer as chief medical officer

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

InnovAge Appoints James Carlson to Its Board of Directors and as Non-Executive Chairman

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Price target decreased to US$4.70

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Price target decreased to US$5.00

Less than half of directors are independent

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Kaskela Law LLC Announces Class Action Lawsuit Against Innovage Holding Corp. and Encourages Long-Term Investors to Contact the Firm

InnovAge Holding Corp. to Report Q2, 2022 Results on Feb 09, 2022

InnovAge Holding Corp. Withdraws Fiscal Year 2022 Guidance

Investor sentiment deteriorated over the past week

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

First quarter 2022 earnings released: EPS US$0.057 (vs US$0.15 loss in 1Q 2021)

Full year 2021 earnings released: US$0.36 loss per share (vs US$0.20 profit in FY 2020)

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2022

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Third quarter 2021 earnings released: US$0.087 loss per share (vs US$0.076 profit in 3Q 2020)

InnovAge Holding Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

President recently bought US$249k worth of stock

InnovAge Holding Corp. Announces Board Appointments

InnovAge Holding Corp. has completed an IPO in the amount of $350.000007 million.